Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

SUSTOL

GRANISETRON

Standard Dose
10MG/0.4ML (10MG/0.4ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SUSTOL is listed in Drugs@FDA under application 022445 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GRANISETRON Form and strength INJECTABLE;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML) Sponsor HERON THERAPS INC Submission history Latest submission status date: 2026-02-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview SUSTOL is listed in Drugs@FDA under application 022445 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GRANISETRON Form and strength INJECTABLE;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML) Sponsor HERON THERAPS INC Submission history Latest submission status date: 2026-02-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.